NO983955L - Nye erytromycinderivater, metode for fremstilling av disse og anvendelse derav som legemidler - Google Patents

Nye erytromycinderivater, metode for fremstilling av disse og anvendelse derav som legemidler

Info

Publication number
NO983955L
NO983955L NO983955A NO983955A NO983955L NO 983955 L NO983955 L NO 983955L NO 983955 A NO983955 A NO 983955A NO 983955 A NO983955 A NO 983955A NO 983955 L NO983955 L NO 983955L
Authority
NO
Norway
Prior art keywords
pharmaceuticals
preparation
erythromycin derivatives
new erythromycin
radical
Prior art date
Application number
NO983955A
Other languages
English (en)
Norwegian (no)
Other versions
NO983955D0 (no
Inventor
Constantin Agouridas
Jean-Fran Ois Chantot
Original Assignee
Hoechst Marion Roussel Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Marion Roussel Inc filed Critical Hoechst Marion Roussel Inc
Publication of NO983955L publication Critical patent/NO983955L/no
Publication of NO983955D0 publication Critical patent/NO983955D0/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08—Hetero rings containing eight or more ring members, e.g. erythromycins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H1/00—Processes for the preparation of sugar derivatives
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Communicable Diseases (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
NO983955A 1996-02-28 1998-08-27 Nye erytromycinderivater, metode for fremstilling av disse og anvendelse derav som legemidler NO983955D0 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9602472A FR2745290B1 (fr) 1996-02-28 1996-02-28 Nouveaux derives de l'erythromycine, leur procede de preparation et leur application comme medicaments
PCT/FR1997/000351 WO1997031929A1 (fr) 1996-02-28 1997-02-27 Nouveaux derives de l'erythromycine, leur procede de preparation et leur application comme medicaments

Publications (2)

Publication Number Publication Date
NO983955L true NO983955L (no) 1998-08-27
NO983955D0 NO983955D0 (no) 1998-08-27

Family

ID=9489659

Family Applications (1)

Application Number Title Priority Date Filing Date
NO983955A NO983955D0 (no) 1996-02-28 1998-08-27 Nye erytromycinderivater, metode for fremstilling av disse og anvendelse derav som legemidler

Country Status (31)

Country Link
US (1) US6096714A (xx)
EP (1) EP0885234B1 (xx)
JP (1) JP4102440B2 (xx)
KR (1) KR100486053B1 (xx)
CN (1) CN1168734C (xx)
AP (1) AP952A (xx)
AR (1) AR005999A1 (xx)
AT (1) ATE217633T1 (xx)
AU (1) AU716204B2 (xx)
BG (1) BG63207B1 (xx)
BR (1) BR9707709B1 (xx)
CZ (1) CZ293893B6 (xx)
DE (1) DE69712610T2 (xx)
DK (1) DK0885234T3 (xx)
EA (1) EA001376B1 (xx)
EE (1) EE9800265A (xx)
ES (1) ES2176698T3 (xx)
FR (1) FR2745290B1 (xx)
HU (1) HU227567B1 (xx)
IL (1) IL125622A (xx)
NO (1) NO983955D0 (xx)
NZ (1) NZ331600A (xx)
OA (1) OA10845A (xx)
PL (1) PL191736B1 (xx)
PT (1) PT885234E (xx)
SK (1) SK118498A3 (xx)
TR (1) TR199801713T2 (xx)
UA (1) UA58504C2 (xx)
WO (1) WO1997031929A1 (xx)
YU (1) YU37098A (xx)
ZA (1) ZA971659B (xx)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU9649698A (en) * 1997-10-29 1999-05-17 Taisho Pharmaceutical Co., Ltd. Erythromycin a 11, 12-carbamate derivatives
WO1999021869A1 (en) * 1997-10-29 1999-05-06 Taisho Pharmaceutical Co., Ltd. Erythromycin a, 11,12-carbamate derivatives
FR2792637B1 (fr) * 1999-04-26 2001-06-01 Hoechst Marion Roussel Inc Nouveaux derives de l'erythromycine, leur procede de preparation et leur application comme medicaments
FR2780977B1 (fr) * 1998-07-09 2000-09-01 Hoechst Marion Roussel Inc Nouveaux derives de l'erythromycine, leur procede de preparation et leur application comme medicaments
JP4573925B2 (ja) * 1998-07-09 2010-11-04 アベンティス・ファーマ・ソシエテ・アノニム 新規のエリスロマイシン誘導体、その製造方法及びその薬剤としての使用
FR2781484B1 (fr) * 1998-07-21 2001-08-10 Hoechst Marion Roussel Inc Nouveaux derives de la 6-deoxy erythromycine, leur procede de preparation et leur application comme medicaments
HUP0105190A3 (en) 1999-01-27 2003-03-28 Pfizer Prod Inc Ketolide antibiotics, medicaments containing them and their use
CN1351608A (zh) * 1999-05-24 2002-05-29 辉瑞产品公司 13－甲基红霉素衍生物
WO2001010878A1 (fr) * 1999-08-06 2001-02-15 Taisho Pharmaceutical Co., Ltd. Derives d'erythromycine a
AU6183800A (en) * 1999-08-06 2001-03-05 Taisho Pharmaceutical Co., Ltd. Erythromycin a derivatives
AU6316400A (en) * 1999-08-06 2001-03-05 Taisho Pharmaceutical Co., Ltd. Erythromycin a derivatives
EP1146051A3 (en) * 2000-04-10 2001-10-31 Pfizer Products Inc. Erythromycin A derivatives
US20020115621A1 (en) * 2000-08-07 2002-08-22 Wei-Gu Su Macrolide antibiotics
ITMI20021726A1 (it) 2002-08-01 2004-02-02 Zambon Spa Macrolidi ad attivita' antiinfiammatoria.
US7601695B2 (en) 2003-03-10 2009-10-13 Optimer Pharmaceuticals, Inc. Antibacterial agents
US20050014706A1 (en) * 2003-07-14 2005-01-20 Kanakeshwari Falzari Method of treating tuberculosis
WO2007069264A2 (en) * 2005-12-15 2007-06-21 Alembic Limited Reference standards for determining the purity of telithromycin and processes therefor
CN101917850B (zh) * 2007-10-25 2016-01-13 森普拉制药公司 大环内酯类抗菌剂的制备方法
ES2565083T3 (es) 2008-10-24 2016-03-31 Cempra Pharmaceuticals, Inc. Biodefensas usando macrólidos que contienen triazol
US9937194B1 (en) 2009-06-12 2018-04-10 Cempra Pharmaceuticals, Inc. Compounds and methods for treating inflammatory diseases
CN108310000A (zh) 2009-09-10 2018-07-24 森普拉制药公司 治疗疟疾、结核病和mac疾病的方法
CN103080122A (zh) 2010-03-22 2013-05-01 森普拉制药公司 大环内脂的结晶形式及其用途
RU2608390C2 (ru) 2010-05-20 2017-01-18 Семпра Фармасьютикалз, Инк. Способы получения макролидов и кетолидов, и промежуточных соединений для их получения
KR20130120458A (ko) 2010-09-10 2013-11-04 셈프라 파마슈티컬스, 인크. 질환을 치료하기 위한 수소결합 형성 플루오로 케토라이드
KR20140139083A (ko) 2012-03-27 2014-12-04 셈프라 파마슈티컬스, 인크. 마크롤라이드계 항생제를 투여하기 위한 비경구 제제
JP6426696B2 (ja) 2013-03-14 2018-11-21 センプラ ファーマシューティカルズ，インコーポレイテッド 呼吸器疾患の治療のための方法および製剤
AU2014233240B2 (en) 2013-03-15 2018-08-09 Cempra Pharmaceuticals, Inc. Convergent processes for preparing macrolide antibacterial agents

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US487411A (en) * 1892-12-06 Island
IL114589A (en) * 1990-11-21 1999-12-22 Roussel Uclaf Intermediates for the preparation of the history of erythromycin
US5444031A (en) * 1993-01-21 1995-08-22 Calgon Carbon Corporation Process for making catalytic carbon
FR2727969B1 (fr) * 1994-12-09 1997-01-17 Roussel Uclaf Nouveaux derives de l'erythromycine, leur procede de preparation et leur application comme medicaments

Also Published As

Publication number Publication date
EP0885234A1 (fr) 1998-12-23
IL125622A0 (en) 1999-04-11
DE69712610D1 (de) 2002-06-20
EA199800768A1 (ru) 1999-02-25
BG102691A (en) 1999-06-30
HUP9902576A3 (en) 2001-03-28
KR19990087324A (ko) 1999-12-27
DK0885234T3 (da) 2002-08-26
NZ331600A (en) 1999-08-30
HUP9902576A1 (hu) 1999-12-28
PL328608A1 (en) 1999-02-01
YU37098A (sh) 1999-07-28
EA001376B1 (ru) 2001-02-26
DE69712610T2 (de) 2002-11-28
PL191736B1 (pl) 2006-06-30
ES2176698T3 (es) 2002-12-01
BG63207B1 (bg) 2001-06-29
EP0885234B1 (fr) 2002-05-15
FR2745290A1 (fr) 1997-08-29
CZ258798A3 (cs) 1998-12-16
BR9707709B1 (pt) 2014-10-14
ZA971659B (en) 1998-02-26
PT885234E (pt) 2002-10-31
CZ293893B6 (cs) 2004-08-18
JP4102440B2 (ja) 2008-06-18
FR2745290B1 (fr) 1998-04-03
AU1929897A (en) 1997-09-16
OA10845A (fr) 2003-02-05
HU227567B1 (en) 2011-08-29
EE9800265A (et) 1999-02-15
BR9707709A (pt) 1999-04-06
TR199801713T2 (xx) 1998-12-21
NO983955D0 (no) 1998-08-27
SK118498A3 (en) 1999-07-12
AP952A (en) 2001-03-29
AR005999A1 (es) 1999-07-21
KR100486053B1 (ko) 2005-06-16
AP9801318A0 (en) 1998-09-30
WO1997031929A1 (fr) 1997-09-04
UA58504C2 (uk) 2003-08-15
AU716204B2 (en) 2000-02-24
IL125622A (en) 2003-10-31
CN1212700A (zh) 1999-03-31
US6096714A (en) 2000-08-01
CN1168734C (zh) 2004-09-29
JP2000505469A (ja) 2000-05-09
ATE217633T1 (de) 2002-06-15

Similar Documents

Publication Publication Date Title
NO983955L (no) Nye erytromycinderivater, metode for fremstilling av disse og anvendelse derav som legemidler
AU5047793A (en) New derivatives of erythromycin, their preparation process, their use as medicaments
TW341573B (en) New erythromycin derivatives, their preparation process and their use as medicaments
NO970175L (no) Pyrido-annellerte tienyl- og furanyl-oksazolidinoner
TR199800409T1 (xx) Kalp ve b�brek yetersizli�inin tedavii�in yeni 4-(oksialkoksifenil)-3-oksi-piperidinler
DK0698010T3 (da) N-acylsulfaminsyreestere (eller thioestere), N-acylsulfonamider og N-sulfonylcarbaminsyreestere (eller thioestere) som hype
NO972909L (no) Substituerte azetidin-2-oner for behandling av atherosklerose
FR2662441B1 (fr) Procede de preparation enantioselective de derives de la phenylisoserine.
EA199800109A1 (ru) Производные азетидинона для лечения атеросклероза
NO961000L (no) Piperidinderivater, fremgangsmåte for fremstilling derav og medikament og preparat inneholdende slike
ES2060021T3 (es) Composiciones reactivas con isocianatos.
DK0974598T3 (da) Hidtil ukendte erythromcinderivater, fremgangsmådetil fremstillingheraf og anvendelse heraf som lægemidler
NO940018L (no) Fremgangsmåte for fremstilling av svovelholdige imidazolderivater
YU3099A (sh) Novi derivati eritromicina, postupak za njihovo dobijanje i njihova primena
YU25699A (sh) Novi derivati eritromicina, postupak za njihovu izradu i njihova primena
CA2027542A1 (en) Uv-absorbing cyclic enaminoketones
NO933903L (xx)
NO20002968L (no) Nye uretaner, tio og ditioanaloger, salter derav, medikamenter inneholdende nevnte forbindelser og anvendelse og fremgangsmÕte for fremstilling derav
DE69904940T2 (de) 6-deoxy-erythromycin-derivate, ihrer herstellung, und ihrer verwendung als arzneimitteln
TH14179A (th) อนุพันธ์ของ n-(ไฮดรอกซิเอธิล) บิวเทนไดแอมีด
MY101624A (en) Novel compounds and prosesses.
TH23883B (th) อนุพันธ์ของพิริมิดินิลพิแรโซล
TH13348EX (th) อนุพันธ์ 1-เมธิลคาร์แบพีเนม การเตรียมสารเหล่านั้นและการใช้สารเหล่านั้นเป็นสารปฏิชีวนะ

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application